We are live on ! Find out more
SP

SIH Partners Portfolio holdings

AUM $7.58B
1-Year Est. Return 5.28%
This Fund
S&P 500
This Quarter Est. Return
+0.43%
1 Year Est. Return
+5.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.95B
AUM Growth
+$974M
Cap. Flow
+$1.05B
Cap. Flow %
35.62%
Top 10 Hldgs %
65.51%
Holding
315
New
184
Increased
39
Reduced
33
Closed
45

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.41%
2 Financials 5.13%
3 Healthcare 5.02%
4 Communication Services 1.71%
5 Materials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXR icon
176
PUT
Extra Space Storage
EXR
$31.2B
$401K 0.01%
2,700
-2,700
-50% -$409K
XLV icon
177
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$397K 0.01%
+2,718
New +$395K
SRPT icon
178
Sarepta Therapeutics
SRPT
$1.66B
$374K 0.01%
+5,867
New +$618K
EW icon
179
Edwards Lifesciences
EW
$47.6B
$374K 0.01%
+5,158
New +$369K
IONS icon
180
Ionis Pharmaceuticals
IONS
$9.35B
$362K 0.01%
+11,999
New +$393K
AXSM icon
181
Axsome Therapeutics
AXSM
$12.4B
$358K 0.01%
+3,071
New +$350K
BPMC
182
DELISTED
Blueprint Medicines
BPMC
$356K 0.01%
+4,027
New +$393K
GEHC icon
183
GE HealthCare
GEHC
$27.6B
$345K 0.01%
+4,277
New +$368K
RMD icon
184
ResMed
RMD
$28.3B
$345K 0.01%
+1,542
New +$360K
FL
185
DELISTED
Foot Locker
FL
$343K 0.01%
+24,319
New +$451K
AEM icon
186
Agnico Eagle Mines
AEM
$72.6B
$342K 0.01%
+3,158
New +$302K
ALKS icon
187
Alkermes
ALKS
$8.82B
$338K 0.01%
+10,234
New +$334K
CRSP icon
188
CRISPR Therapeutics
CRSP
$4.58B
$330K 0.01%
+9,712
New +$412K
KRYS icon
189
Krystal Biotech
KRYS
$9.88B
$327K 0.01%
+1,815
New +$305K
CAH icon
190
Cardinal Health
CAH
$53.4B
$327K 0.01%
+2,370
New +$302K
TWST icon
191
Twist Bioscience
TWST
$5.62B
$326K 0.01%
+8,311
New +$374K
EPAM icon
192
EPAM Systems
EPAM
$4.69B
$317K 0.01%
1,878
ADBE icon
193
Adobe
ADBE
$89.5B
$316K 0.01%
+823
New +$353K
HUM icon
194
Humana
HUM
$46.7B
$314K 0.01%
+1,187
New +$321K
BNS icon
195
Scotiabank
BNS
$106B
$312K 0.01%
+6,569
New +$330K
PCVX icon
196
Vaxcyte
PCVX
$7.89B
$306K 0.01%
+8,109
New +$648K
CNC icon
197
Centene
CNC
$31.3B
$305K 0.01%
+5,016
New +$303K
GLOB icon
198
Globant
GLOB
$1.35B
$303K 0.01%
2,574
VRNA
199
DELISTED
Verona Pharma
VRNA
$302K 0.01%
+4,755
New +$284K
NUVL
200
DELISTED
Nuvalent
NUVL
$296K 0.01%
+4,169
New +$326K

Similar funds

SIH Partners's Q1 2025 Portfolio in Review

As of Q1 2025, SIH Partners held 315 positions worth $2.95B, up 49% from $1.98B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SIH Partners deployed $1.05B of net new capital in Q1 2025, opening 184 new positions and adding to 39 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $115M trimmed.

  • SIH Partners's largest Q1 2025 buy was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.
  • SIH Partners added most to Stellantis in Q1 2025, an estimated $38.7M increase.
  • SIH Partners's biggest Q1 2025 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $115M.
  • SIH Partners fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $263M.
  • SIH Partners's ten largest holdings make up 66% of its $2.95B portfolio in Q1 2025.
  • SIH Partners opened 184 new positions and closed 45 in Q1 2025.
  • SIH Partners's portfolio value rose 49% quarter-over-quarter to $2.95B.

Based on SIH Partners's 13F filing for Q1 2025, filed 15 May 2025.